Cost-effectiveness of asthma control: an economic appraisal of the GOAL study

Allergy
A H BriggsGOAL Investigators Group

Abstract

The Gaining Optimal Asthma ControL (GOAL) study has shown the superiority of a combination of salmeterol/fluticasone propionate (SFC) compared with fluticasone propionate alone (FP) in terms of improving guideline defined asthma control. Clinical and economic data were taken from the GOAL study, supplemented with data on health related quality of life, in order to estimate the cost per quality adjusted life year (QALY) results for each of three strata (previously corticosteroid-free, low- and moderate-dose corticosteroid users). A series of statistical models of trial outcomes was used to construct cost effectiveness estimates across the strata of the multinational GOAL study including adjustment to the UK experience. Uncertainty was handled using the non-parametric bootstrap. Cost-effectiveness was compared with other treatments for chronic conditions. Salmeterol/fluticasone propionate improved the proportion of patients achieving totally and well-controlled weeks resulting in a similar QALY gain across the three strata of GOAL. Additional costs of treatment were greatest in stratum 1 and least in stratum 3, with some of the costs offset by reduced health care resource use. Cost-effectiveness by stratum was 7600 pound (95% CI:...Continue Reading

References

Dec 1, 1994·Statistical Methods in Medical Research·A P Grieve
Jun 1, 1994·Current Opinion in Immunology·R J Armitage
Jun 1, 1996·Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B·E MolteniE Ginelli
Jan 12, 2001·The European Respiratory Journal·K F RabeW C Maier
Aug 21, 2001·The European Respiratory Journal·P Bergquist, G K Crompton
Oct 3, 2002·The European Respiratory Journal·E D BatemanG L Braunstein
Apr 15, 2004·Social Science & Medicine·Lori Curtis, Shelley Phipps
Jul 17, 2004·American Journal of Respiratory and Critical Care Medicine·Eric D BatemanUNKNOWN GOAL Investigators Group
Jul 24, 2004·BMJ : British Medical Journal·Michael D Rawlins, Anthony J Culyer

❮ Previous
Next ❯

Citations

Aug 28, 2010·Pharmacy World & Science : PWS·Kwua-Yun WangChin-Pyng Wu
Aug 28, 2013·PharmacoEconomics·Pepijn Vemer, Maureen P M H Rutten-van Mölken
Aug 29, 2006·Lancet·Paul M O'Byrne, Krishnan Parameswaran
Dec 6, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jonathan D CampbellSean D Sullivan
Nov 26, 2011·BMC Pulmonary Medicine·Persijn J HonkoopJacob K Sont
Aug 2, 2008·Environmental Health : a Global Access Science Source·Michelle L BellGeorge D Thurston
Apr 8, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yuji TohdaTerumasa Miyamoto
Jul 28, 2011·Journal of Asthma and Allergy·Gavin Dalglish, Graham Priestley
Sep 2, 2009·Drugs·Kate McKeage, Susan J Keam
Nov 22, 2013·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Thomas ReinholdClaudia Witt
Sep 4, 2009·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Ronald J HalbertShao-Lee Lin
Mar 5, 2015·Journal of Medical Economics·Thomas R EinarsonMichiel E H Hemels
Sep 18, 2015·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Joe G ZeinBelinda L Udeh
May 24, 2007·Current Medical Research and Opinion·Iolo DoullHelen Rudge
Nov 4, 2015·Allergy·Mohsen SadatsafaviUNKNOWN Economic Burden of Asthma Study Group
Oct 7, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Robert S ZeigerAniket A Kawatkar
Nov 3, 2009·Pulmonary Pharmacology & Therapeutics·Alan Kaplan, Dermot Ryan
Dec 22, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Mohsen SadatsafaviUNKNOWN Economic Burden of Asthma (EBA) Study Group
Apr 10, 2007·Respiratory Medicine·Roberto Walter Dal NegroMarco Sandri
May 31, 2014·The Journal of Allergy and Clinical Immunology·Zafar ZafariMohsen Sadatsafavi
Sep 7, 2016·The Journal of Allergy and Clinical Immunology·Robert F LemanskePaul Williams
Apr 2, 2013·The Cochrane Database of Systematic Reviews·Christopher J CatesMontse Ferrer
Dec 7, 2018·The Cochrane Database of Systematic Reviews·Christopher J CatesSamuel Waterson
Apr 25, 2006·Allergy·M Humbert
Jan 1, 2008·Journal of Medical Economics·Leandro Fritscher, Kenneth R Chapman
Oct 6, 2007·Wiener medizinische Wochenschrift·Viktoria SteinAnita Rieder
May 14, 2018·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Rebecca ForsterWilliam C N Dunlop
Jun 28, 2018·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Jenny RetzlerMercedes Romano Rodriguez
Jan 1, 2020·Diabetology & Metabolic Syndrome·Fahimeh Ramezani Tehrani, UNKNOWN Gulf Study Cooperative Research Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.